Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rose Hurren

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 3, 2015
Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cellsDannie Bernard, Marinella Gebbia, Swayam Prabha, et al.
Nature Communications|May 30, 2026
Mitochondrial RNA degradation regulates differentiation, stemness, and immune sensitivity in acute myeloid leukemiaGeethu Emily Thomas, Veronique Voisin, Kazem Nouri, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Blood|January 16, 2010
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG Wei Xu, Mohsin Ali, Tabitha E Wood, et al.
Haematologica|November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killingYael Morgenstern, JongBok Lee, Yoosu Na, et al.
Haematologica|November 9, 2023
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidaseDanny V Jeyaraju, Maryam Alapa, Ann Polonskaia, et al.
Cancer Research|October 20, 2011
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancersSiyuan Song, Tania Christova, Stephen Perusini, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 3, 2015
Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cellsDannie Bernard, Marinella Gebbia, Swayam Prabha, et al.
Nature Communications|May 30, 2026
Mitochondrial RNA degradation regulates differentiation, stemness, and immune sensitivity in acute myeloid leukemiaGeethu Emily Thomas, Veronique Voisin, Kazem Nouri, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Blood|January 16, 2010
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG Wei Xu, Mohsin Ali, Tabitha E Wood, et al.
Haematologica|November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killingYael Morgenstern, JongBok Lee, Yoosu Na, et al.
Haematologica|November 9, 2023
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidaseDanny V Jeyaraju, Maryam Alapa, Ann Polonskaia, et al.
Cancer Research|October 20, 2011
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancersSiyuan Song, Tania Christova, Stephen Perusini, et al.
Pageof 7